Tully on for Steven Willey

Managing Director and Senior Equity Research Analyst at Stifel Financial Corp.

Stephen Willey is a Managing Director and Senior Equity Research Analyst at Stifel, specializing in the biotechnology sector within healthcare. He covers a diverse range of biotechnology companies and has established a solid performance track record, with a 71% buy rating ratio and 7.8% average return noted on TipRanks and an overall analyst ranking around 3000. Willey began his career as a Research Scientist at ImClone Systems and Research Associate at Mount Sinai School of Medicine, later joining Thomas Weisel Partners before the 2010 acquisition by Stifel. He holds an undergraduate degree from the University of New Hampshire, an MBA from New York University, an M.S. from the University of Rhode Island, and is registered with FINRA.